Ratios	Dec 24	Dec 23	Dec 22	Dec 21
Liquidity Ratios
Current Ratio	―	0.19	0.23	0.18
Quick Ratio	―	0.18	0.15	0.09
Cash Ratio	―	0.09	0.06	0.02
Solvency Ratio	―	-1.54	-0.98	-1.11
Operating Cash Flow Ratio	―	0.00	0.00	0.00
Short-Term Operating Cash Flow Coverage	―	0.00	0.00	0.00
Net Current Asset Value	AU$ ―	AU$ -9.07M	AU$ -13.87M	AU$ -15.59M
Leverage Ratios
Debt-to-Assets Ratio	―	3.36	0.10	0.06
Debt-to-Equity Ratio	―	-0.96	-0.20	-0.08
Debt-to-Capital Ratio	―	-24.18	-0.25	-0.08
Long-Term Debt-to-Capital Ratio	―	0.00	0.00	0.00
Financial Leverage Ratio	―	-0.29	-2.09	-1.32
Debt Service Coverage Ratio	―	-2.13	-32.69	-59.48
Interest Coverage Ratio	―	-301.01	-37.85	-46.28
Debt to Market Cap	―	0.00	0.00	0.00
Interest Debt Per Share	―	0.00	0.04	0.31
Net Debt to EBITDA	―	-0.43	-0.02	-0.02
Profitability Margins
Gross Profit Margin	―	76.50%	22.86%	42.82%
EBIT Margin	―	-3049.63%	-1915.19%	-613.85%
EBITDA Margin	―	-2914.38%	-1770.00%	-591.65%
Operating Profit Margin	―	-2646.84%	-2049.40%	-460.46%
Pretax Profit Margin	―	-3058.43%	-1969.34%	-623.80%
Net Profit Margin	―	-3058.43%	-1967.34%	-614.71%
Continuous Operations Profit Margin	―	-3058.43%	-1969.34%	-623.86%
Net Income Per EBT	―	100.00%	99.90%	98.54%
EBT Per EBIT	―	115.55%	96.09%	135.47%
Return on Assets (ROA)	―	-723.12%	-162.51%	-210.75%
Return on Equity (ROE)	―	206.77%	340.24%	277.42%
Return on Capital Employed (ROCE)	―	184.66%	1315.01%	461.79%
Return on Invested Capital (ROIC)	―	4766.67%	1567.67%	489.40%
Return on Tangible Assets	―	-723.12%	-162.51%	-210.75%
Earnings Yield	―	0.00%	-139.31%	-1726.83%
Efficiency Ratios
Receivables Turnover	―	1.55	1.87	6.38
Payables Turnover	―	0.08	0.72	0.89
Inventory Turnover	―	1.03	0.79	1.54
Fixed Asset Turnover	―	1.33	0.13	0.45
Asset Turnover	―	0.24	0.08	0.34
Working Capital Turnover Ratio	―	-0.06	-0.09	-0.57
Cash Conversion Cycle	―	-4.24K	151.82	-117.28
Days of Sales Outstanding	―	235.00	195.19	57.25
Days of Inventory Outstanding	―	353.15	464.69	237.35
Days of Payables Outstanding	―	4.83K	508.06	411.88
Operating Cycle	―	588.15	659.88	294.60
Cash Flow Ratios
Operating Cash Flow Per Share	―	0.00	0.00	0.00
Free Cash Flow Per Share	―	0.00	-0.39	-3.83
CapEx Per Share	―	0.00	<0.01	0.25
Free Cash Flow to Operating Cash Flow	―	0.00	0.00	0.00
Dividend Paid and CapEx Coverage Ratio	―	0.00	0.00	0.00
Capital Expenditure Coverage Ratio	―	0.00	0.00	0.00
Operating Cash Flow Coverage Ratio	―	0.00	0.00	0.00
Operating Cash Flow to Sales Ratio	―	0.00	0.00	0.00
Free Cash Flow Yield	―	0.00%	-114.44%	-933.72%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	0.00	-0.72	-0.06
Price-to-Sales (P/S) Ratio	―	0.00	14.12	0.36
Price-to-Book (P/B) Ratio	―	0.00	-2.44	-0.16
Price-to-Free Cash Flow (P/FCF) Ratio	―	0.00	-0.87	-0.11
Price-to-Operating Cash Flow Ratio	―	0.00	0.00	0.00
Price-to-Earnings Growth (PEG) Ratio	―	0.00	<0.01	>-0.01
Price-to-Fair Value	―	0.00	-2.44	-0.16
Enterprise Value Multiple	―	-0.43	-0.82	-0.08
Enterprise Value	―	7.26M	12.93M	1.54M
EV to EBITDA	―	-0.43	-0.82	-0.08
EV to Sales	―	12.45	14.51	0.45
EV to Free Cash Flow	―	-0.78	-0.90	-0.14
EV to Operating Cash Flow	―	0.00	0.00	0.00
Tangible Book Value Per Share	―	0.00	-0.16	-2.77
Shareholders’ Equity Per Share	―	0.00	-0.14	-2.55
Tax and Other Ratios
Effective Tax Rate	―	0.00	0.00	>-0.01
Revenue Per Share	―	0.00	0.02	1.15
Net Income Per Share	―	0.00	-0.47	-7.08
Tax Burden	―	1.00	1.00	0.99
Interest Burden	―	1.00	1.03	1.02
Research & Development to Revenue	―	6.16	2.61	0.59
SG&A to Revenue	―	13.76	9.73	3.58
Stock-Based Compensation to Revenue	―	0.00	0.00	0.00
Income Quality	―	0.00	0.00	0.00

Argent Biopharma (RGT) Ratios

Argent Biopharma Ratios